Romazicon   body {font-family: 'Open Sans', sans-serif;} .ui-header .ui-title, .ui-footer .ui-title { margin-right: 0 !important; margin-left: 0 !important; } \* { margin:0px; padding:0px;} .ui-page { background: #f2f2f2 url(bg.jpg); line-height:1.5em;} #home\_link { color:#FFF; text-decoration:none; cursor:pointer; font-family:'AndikaBasicRegular',Arial, sans-serif; font-size:0.9em; margin-left:15%; } #home\_link span {font-size:0.6em;margin-left:15%; color: #D8D8D8; } h1 {font-family:'AndikaBasicRegular'; }

# Romazicon

**Romazicon (Flumazenil)**  
**Class:** Benzodiazepine Antidote (antagonist).  
Competitive antagonist of GABA receptors.  
It prevents or reverses, in a dose-dependent manner, all the antagonistic effects of Benzodiazepines.  
**Indication:** Benzodiazepine reversal.  
**Doses:** (should titrate to LOC).  
**Popular Initial dose:** 0.2mg IV (8-15ug/kg) works within 2 minutes.  
If more is needed, re-dose with increments of 0.1mg at a time.  
**Average dose:** 0.3-0.6mg IV.  
**Max Dose:** suggested 3mg  
0.5-1.0 mg is usually enough for a full reversal.  
**Peds:** 0.01mg/kg IV, no faster than 0.2mg/min.  
**Drip:** 0.1-0.4mg/hr.  
**Duration:** only 30-60 minutes. May require redose.  
**Half life:** 54 minutes.  
**Metabolism:** microsomal enzymes to inactive metabolites.  
If there is no reversal or increased LOC after 5mg, it is safe to assume that another drug or drugs are involved.  
**Adverse Reactions**  
Seizure, N/V, Arrythmias, HTN, pain at site.  
**Caution:** Avoid with seizure patients on antiepileptics.  
About Romazicon  
Romazicon administered at 10 times the recommended dose still has no agonist effect on resting ventilation or psychomotor performance in normal individuals.

#### Copyright Â© 2012